Jazz Pharmaceuticals $575 million 1.5% notes issue

22/9/2017

Investment grade bond/note issue

Value:

$ 575 million

Status:

Completed

Date:

22/9/2017

Overview:

Jazz Pharmaceuticals has issued $575 million in senior notes.
The 1.5% notes are due 2024.
The offering was made through subsidiary Jazz Investments I.
The proceeds will be used to repay existing debt.

Katrin Kostadinova - Data analyst

Jurisdictions:

United States
Ireland

Deal type:

Investment grade bond/note issue

Practice area:

Capital markets : Debt

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences

Firms:

Cooley

Party: Jazz Pharmaceuticals (Issuer)

Lawyers: Chadwick Mills, Charlie Kim, Mischi a Marca

Related deals